Skip to main content
Macrogen, Inc. logo

Macrogen, Inc. — Investor Relations & Filings

Ticker · 038290 ISIN · KR7038290003 KO Professional, scientific and technical activities
Open in API
Filings indexed 352 across all filing types
Latest filing 2019-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 038290

About Macrogen, Inc.

https://www.macrogen.com/en/main

Macrogen, Inc. is a biotechnology company specializing in precision medicine and genomic analysis. It provides a comprehensive suite of services, including Next-Generation Sequencing (NGS), Sanger sequencing, and spatial transcriptome analysis, to a global client base. The company's core activities are focused on three key areas: Research and Data Analysis, offering fast and accurate genomic services to the scientific community; Clinical Diagnostics, advancing disease prediction through the integration of genomic and medical big data; and Personal Healthcare, providing genetic tests for wellness, nutrition, and disease risk assessment. By combining its extensive genomic expertise with big data and AI, Macrogen aims to deliver hyper-personalized healthcare solutions and innovate in the field of future medicine.

Recent filings

Filing Released Lang Actions
분기보고서 (2019.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Macrogen' (주)마크로젠 for the period of 2019-01-01 to 2019-03-31. It contains detailed financial data, business descriptions, and management information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2019
2019-05-15 Korean
신탁계약에의한취득상황보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on Acquisition Status by Trust Agreement' (신탁계약등에의한취득상황보고서) filed by Macrogen with the Financial Supervisory Service of South Korea. This document specifically details the status of a share buyback program conducted through a trust agreement. According to the filing definitions, reports regarding a company buying back its own shares are classified as 'Transaction in Own Shares' (POS).
2019-04-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document tracks changes in share ownership by major shareholders and their special relations (insiders). It details the reporting entity, the number of shares held, the purpose of holding, and specific changes (in this case, stock option grants). This falls under the category of 'Major Shareholding Notification' (MRQ) as it tracks significant ownership thresholds and changes.
2019-04-02 Korean
사업보고서 (2018.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Consolidated Audit Report' (연결감사보고서) for Macrogen Inc. for the fiscal year ending December 31, 2018. It includes the independent auditor's report, consolidated financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes to the financial statements. Since it covers a full fiscal year and contains substantive financial data, it is classified as an Annual Report (10-K equivalent in the Korean regulatory context). FY 2018
2019-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Regular General Meeting of Shareholders Results) and provides the official outcomes of the voting items (approval of financial statements, amendments to articles of incorporation, director compensation, and stock options) held on 2019-03-26. This falls under the category of Declaration of Voting Results.
2019-03-26 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to directors and employees, including exercise prices, vesting periods, and valuation methods. Since this document pertains to the issuance of new rights/shares (stock options) and does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for capital changes), it is classified as a general regulatory filing.
2019-03-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.